Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
正在載入互動式股價圖表...
- Zacks
Pharma Stock Roundup: FDA Approves J&J's Tremfya for Ulcerative Colitis & More
FDA approves J&J's Tremfya for ulcerative colitis. NVO's oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.
- Zacks
Sanofi, Regeneron's Dupixent Meets Late-Stage Urticaria Study Goals
This is the second pivotal late-stage study on SNY/REGN's Dupixent in chronic spontaneous urticaria indication to meet primary and key secondary endpoints.
- Motley Fool
Prediction: These 2 Companies Will Split Their Stocks by 2027
Eli Lilly and Regeneron Pharmaceuticals are good stock-split candidates thanks to years of successes.
